Interestingly, measurements of mRNAs levels, performed on multiple subsets of oncology patients, evidenced that TRF2 and NAMPT positively correlate with each other in Breast Cancer (BC), in which we demonstrated that co‐expression of these two factors correlates with a more aggressive tumor phenotype and, consequently, with a worst prognosis. Here, NAMPT is linked to breast carcinoma.